Dear Colleagues,
We are pleased to announce the winners of the IJMS 2022 Best Paper Award. All papers published in 2022 in IJMS were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, six winners were selected.
Three Articles:
Single-Cell RNA-Seq Analysis of Cells from Degenerating and Non-Degenerating Intervertebral Discs from the Same Individual Reveals New Biomarkers for Intervertebral Disc Degeneration
By Hosni Cherif; Matthew Mannarino; Alain Sarabia Pacis; Jiannis Ragoussis; Oded Rabau; Jean A. Ouellet and Lisbet Haglund
Int. J. Mol. Sci. 2022, 23(7), 3993; https://doi.org/10.3390/ijms23073993
An Interleukin-4 and Interleukin-13 Induced Atopic Dermatitis Human Skin Equivalent Model by a Skin-On-A-Chip
By Kyunghee Kim; Hyeju Kim and Gun Yong Sung
Int. J. Mol. Sci. 2022, 23(4), 2116; https://doi.org/10.3390/ijms23042116
Combined Therapy with a CCR2/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and Fibrosis
By Tobias Puengel; Sander Lefere; Jana Hundertmark et al.
Int. J. Mol. Sci. 2022, 23(12), 6696; https://doi.org/10.3390/ijms23126696
Three Reviews:
Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis
By Piero Portincasa; Leonilde Bonfrate; Mirco Vacca et al.
Int. J. Mol. Sci. 2022, 23(3), 1105; https://doi.org/10.3390/ijms23031105
Plant-Derived Antioxidants: Significance in Skin Health and the Ageing Process
By Monika Michalak
Int. J. Mol. Sci. 2022, 23(2), 585; https://doi.org/10.3390/ijms23020585
The Apoptosis Paradox in Cancer
By Ornella Morana; Will Wood and Christopher D. Gregory
Int. J. Mol. Sci. 2022, 23(3), 1328; https://doi.org/10.3390/ijms23031328
Each winner will receive a certificate and a chance to publish a paper free of charge in IJMS in 2024 after peer review.
Please join us in congratulating the winners of IJMS 2022 Best Paper Award. We would also like to take this opportunity to thank all of our authors for your continued support of IJMS.
Kind regards,
IJMS Editorial Office
Eligibility and Requirements
Photodynamic therapy (PDT) is a two-stage treatment that implies the use of light energy, oxygen, and light-activated compounds (photosensitizers) to elicit cancerous and precancerous cell death after light activation (phototoxicity). The biophysical...
Glioblastoma (GB) stands out as the most prevalent and lethal form of brain cancer. Although great efforts have been made by clinicians and researchers, no significant improvement in survival has been achieved since the Stupp protocol became the stan...
The use of non-coding RNAs (ncRNAs) as drug targets is being researched due to their discovery and their role in disease. Targeting ncRNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), is an attractive approach for treating variou...
The pandemic of coronavirus disease 2019 (COVID-19) has been the foremost modern global public health challenge. The airway is the primary target in severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) infection, with substantial cel...
The advancement of exosome studies has positioned engineered exosomes as crucial biomaterials for the development of advanced drug delivery systems. This study focuses on developing a hybrid exosome system by fusing mesenchymal stem cells (MSCs) exos...
HDAC11 is a class IV histone deacylase with no crystal structure reported so far. The catalytic domain of HDAC11 shares low sequence identity with other HDAC isoforms, which makes conventional homology modeling less reliable. AlphaFold is a machine l...
Maurizio Battino
Antonio Pisani
Manlio Ferrarini
Salah Eddine Stiriba
João Pedro Silva
José L. Quiles
